Cardinal Health has completed its acquisition of Johnson & Johnson’s Cordis cardiology and endovascular device business for $1.944 billion. Cardinal said Sunday evening that the integration of Cordis off to a strong start, with management teams in place worldwide.
Eos Products LLC has reached a settlement that stops a private-label manufacturer and its components supplier from selling knockoff versions of its egg-shaped lip balm. Eos said that OraLabs Inc.
Dr. Fresh LLC’s Reach oral care brand is bringing back an old friend to help promote its expanded Complete Care product lineup. The company said Thursday that Mr.
Nestlé has added to its lineup of treats this fall with the new Nestlé Crunch Peanuts character bars for Halloween and skull-and bone-shaped SweeTarts for Día de los Muertos. The chocolate maker said Wednesday that the Nestlé Crunch Peanuts Molded Fun Size Bars (suggested retail price of $3.
AstraZeneca has released Brilinta (ticagrelor) 60-mg tablets, a smaller dose of the anticoagulant medication, to U.S. pharmacies.
This month, Kirby Lester marked its 10th year under the ownership and leadership of president Garry Zage.
This month, Kimberly-Clark Corp. has begun making its new Poise Impressa Bladder Supports widely available in retail stores. The new product, available online since February, is designed to help women with stress urinary incontinence stop leaks before they occur.
Ted Scherr, president and chief executive officer of Dakota Drug Inc., has been re-elected as chairman of the Healthcare Distribution Management Association (HDMA). HDMA said Tuesday that Jon Giacomin, CEO of the pharmaceutical segment at Cardinal Health Inc.
Andreas Rouvé, president and chief executive officer of Spectrum Brands Holdings Inc., has been elected to the company’s board of directors. Spectrum Brands said Monday that Rouvé is slated to join the board on Oct. 1. He became president and CEO on April 1.
Aurobindo Pharma Ltd. has received approval from the Food and Drug Administration for gemfibrozil tablets, omeprazole delayed-release capsules and telmisartan tablets. The company said Monday that its gemfibrozil tablets (600 mg) are a generic version of Lopid tablets from Pfizer Inc.
Endo International plc has completed its $8.05 billion acquisition of Par Pharmaceutical Holdings Inc. from leading global private investment firm TPG. Endo said Monday that with the closing of the deal, announced in May, its U.S.
Camber Pharmaceuticals has launched esomeprazole magnesium delayed-release capsules, a medication for heartburn and gastroesophageal reflux disease (GERD). Camber said its product, available in strengths of 20 mg and 40 mg, is a generic version of Nexium capsules from AstraZeneca.
Skinfix Inc. aims to alleviate chronic dry skin with a range of textures and hydration levels with its new Skinfix Healthy Skin regimen.
A trusted skin care solution for families for decades, Aquaphor has introduced a new product for babies.
Smith Drug Co. has hired Brian Purscell as senior vice president of pharmacy solutions, a newly created position. The J M Smith Corp.
The board of directors at AmerisourceBergen Corp. has authorized a special $2.4 billion share repurchase program.
